"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study".


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
17 Jun 2019
Historique:
received: 24 01 2019
accepted: 06 06 2019
entrez: 19 6 2019
pubmed: 19 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

Asthma is a chronic disease affecting 30 million people in Europe under 45y. Poor control of Asthma is the main cause of emergency-department (ED) access, becoming the strongest determinant of the economic burden of asthma management. To examine the characteristics of adult patients admitted to ED for acute asthma attack, focusing on previous diagnosis of asthma (DA) and current therapy. During a one-year period, a structured questionnaire, assessing asthma diagnosis and management, was administered to all patients admitted for asthma attack, to the ED of a South-Italy town. Only patients with subsequently confirmed asthma were enrolled. The data on oxygen saturation (Sat.O2), heart and respiratory-rate, severity code ED-admission, hospitalization or discharge, had been obtained. Two hundred one patients (mean 50.3ys), were enrolled. One hundred eighteen had a DA, made 17.5 ± 5.88 years before, and 35.6% had a specialist-examination in the last year. 53.3% of DA-patients used a self-medication before ED access with short-acting-beta-2-agonist and oral-corticosteroids, although none had a written-asthma-action-plan (WAAP). Almost all DA-patients were on regular therapy: inhaled-corticosteroids (ICS) in 61%, associated with LABA in 85%. 16.7% of DA-patients had previous DA-access. The overall hospitalization-rate was 39%, higher in DA compared to unknown asthmatic patients (UA)(p = 0.017). Significant risk factors for hospitalization were Sat-O2 ≤ 94% breathing ambient air (OR9.91, p < 0.001), inability-to-complete a sentence (OR9.42,p < 0.001) and the age (OR1.02,p = 0.049). Despite the asthma guidelines-recommendation, up to 40% of patients received the asthma diagnosis in ED, only 61% of DA-patients were taking ICS. It is disappointing that DA-patients did not have a WAAP, which could explain the poor patient-self-medication at ED admission.

Sections du résumé

BACKGROUND BACKGROUND
Asthma is a chronic disease affecting 30 million people in Europe under 45y. Poor control of Asthma is the main cause of emergency-department (ED) access, becoming the strongest determinant of the economic burden of asthma management.
OBJECTIVE OBJECTIVE
To examine the characteristics of adult patients admitted to ED for acute asthma attack, focusing on previous diagnosis of asthma (DA) and current therapy.
METHODS METHODS
During a one-year period, a structured questionnaire, assessing asthma diagnosis and management, was administered to all patients admitted for asthma attack, to the ED of a South-Italy town. Only patients with subsequently confirmed asthma were enrolled. The data on oxygen saturation (Sat.O2), heart and respiratory-rate, severity code ED-admission, hospitalization or discharge, had been obtained.
RESULTS RESULTS
Two hundred one patients (mean 50.3ys), were enrolled. One hundred eighteen had a DA, made 17.5 ± 5.88 years before, and 35.6% had a specialist-examination in the last year. 53.3% of DA-patients used a self-medication before ED access with short-acting-beta-2-agonist and oral-corticosteroids, although none had a written-asthma-action-plan (WAAP). Almost all DA-patients were on regular therapy: inhaled-corticosteroids (ICS) in 61%, associated with LABA in 85%. 16.7% of DA-patients had previous DA-access. The overall hospitalization-rate was 39%, higher in DA compared to unknown asthmatic patients (UA)(p = 0.017). Significant risk factors for hospitalization were Sat-O2 ≤ 94% breathing ambient air (OR9.91, p < 0.001), inability-to-complete a sentence (OR9.42,p < 0.001) and the age (OR1.02,p = 0.049).
CONCLUSION CONCLUSIONS
Despite the asthma guidelines-recommendation, up to 40% of patients received the asthma diagnosis in ED, only 61% of DA-patients were taking ICS. It is disappointing that DA-patients did not have a WAAP, which could explain the poor patient-self-medication at ED admission.

Identifiants

pubmed: 31208388
doi: 10.1186/s12890-019-0869-8
pii: 10.1186/s12890-019-0869-8
pmc: PMC6580601
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Anti-Asthmatic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Références

Eur Respir J. 2000 Nov;16(5):802-7
pubmed: 11153575
Respir Med. 2002 Mar;96(3):142-9
pubmed: 11905548
Allergy. 2003 Mar;58(3):221-8
pubmed: 12653796
Chest. 2005 May;127(5):1579-86
pubmed: 15888831
BMC Pulm Med. 2009 May 19;9:24
pubmed: 19454036
MMWR Morb Mortal Wkly Rep. 2011 May 6;60(17):547-52
pubmed: 21544044
Clin Rev Allergy Immunol. 2012 Aug;43(1-2):14-29
pubmed: 21597902
Int Arch Allergy Immunol. 2013;160(1):93-101
pubmed: 22948386
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):744-51
pubmed: 23559540
Ann Am Thorac Soc. 2014 Feb;11(2):158-66
pubmed: 24298941
J Allergy Clin Immunol. 2015 Jan;135(1):73-80
pubmed: 25263233
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):733-40
pubmed: 25439365
J Asthma. 2015;52(9):931-4
pubmed: 26291138
Rev Mal Respir. 2016 May;33(5):365-76
pubmed: 26545450
Asthma Res Pract. 2017 Jan 6;3:1
pubmed: 28078100
Clin Respir J. 2018 Jun;12(6):2117-2125
pubmed: 29469993
Respir Med. 2018 Sep;142:48-52
pubmed: 30170801

Auteurs

Laura Losappio (L)

Allergy and Immunology Department, Niguarda Ca Granda Hospital, Milan, Italy.

Enrico Heffler (E)

Personalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.

Rossella Carpentiere (R)

Emergency Department, "Dimiccoli" Hospital, Barletta, Italy.

Monica Fornero (M)

Allergy and Immunology Department, Niguarda Ca Granda Hospital, Milan, Italy.

Cosimo Damiano Cannito (CD)

Emergency Department, "Dimiccoli" Hospital, Barletta, Italy.

Francesco Guerrera (F)

Department of Surgical Science, University of Torino, Torino, Italy.

Francesca Puggioni (F)

Personalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.

Riccardo Monti (R)

Allergy and Clinical Immunology Unit, Department of Medical Science, University of Torino and AO Ordine Mauriziano Umberto I, Torino, Italy.

Stefania Nicola (S)

Allergy and Clinical Immunology Unit, Department of Medical Science, University of Torino and AO Ordine Mauriziano Umberto I, Torino, Italy.

Giovanni Rolla (G)

Allergy and Clinical Immunology Unit, Department of Medical Science, University of Torino and AO Ordine Mauriziano Umberto I, Torino, Italy.

Luisa Brussino (L)

Allergy and Clinical Immunology Unit, Department of Medical Science, University of Torino and AO Ordine Mauriziano Umberto I, Torino, Italy. luisa.brussino@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH